Finalized CMS Policy Increases Access to Medication-Assisted Treatment

April 14th, 2016

New policies from the Centers for Medicare and Medicaid Services (CMS) will require Medicare Part D formularies to allow access to medication-assisted treatment for substance use disorders such as buprenorphine, naloxone and naltrexone. The policy is a response to President Obama’s October call to action, directing federal agencies to identify and surmount barriers to treatment for opioid use disorders. CMS said it will continue to review utilization management and formulary tiering to ensure access throughout Medicare Part D.

Read More

Posted in Content

A Project of the Governor's Institute on Alcohol & Substance Abuse and the North Carolina Society of Addiction Medicine.
Funded wholly or in part by the federal Substance Abuse Prevention and Treatment Block Grant Fund (CFDA #93.959) as a project of the NC Division of Mental Health, Developmental Disabilities & Substance Abuse Services.